Based on SEC filing data. A biotech corporation based in Minneapolis raised $399,572 through a convertible note in its Series A funding round. The company operates in the biotechnology sector.
Get notified the moment Gila Therapeutics, Inc. files a new round, hires execs, or shows traction signals.
Create free accountAbout this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.
About this data
FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.